Newcells Biotech Ltd

Newcells Biotech is a life sciences company based in Newcastle upon Tyne, UK, specializing in in vitro tissue models for drug discovery and clinical translation. Founded in 2015 as a spinoff from Newcastle University, the company employs around 42 people and is supported by founders, venture, and private equity investors.

The company focuses on providing physiologically relevant in vitro models that help de-risk decision-making in drug development. Newcells Biotech is recognized for its expertise in cell biology, tissue physiology, bioengineering, and assay development. It is a leading provider of in vitro tissue models in areas such as retina, kidney, and lung airway models, catering to applications like gene therapy, toxicity assessment, and disease modeling. The company offers both bespoke services and commercial products, ensuring all assays meet quality control standards. Newcells Biotech collaborates with pharmaceutical companies, biotechnology firms, and academic centers globally, contributing to numerous studies on efficacy, safety, and drug transport.